Medtronic plcMDT
時価総額
$1296.6億
PER
医療機器・治療デバイス分野の米国最大手。脳血管用コイルやステント、脊髄・脳刺激装置、MiniMed 780Gなどを展開。2025年5月に糖尿病事業の分社化計画発表、2024年2月に人工呼吸器事業撤退。150カ国超で米国・欧州・中国・日本を中心に展開。
| 2015年 4月24日 | 2016年 4月29日 | 2017年 4月28日 | 2018年 4月27日 | 2019年 4月26日 | 2020年 4月24日 | 2021年 4月30日 | 2022年 4月29日 | 2023年 4月28日 | 2024年 4月26日 | 2025年 4月25日 | |
| Net income | - | - | 4,024 | 3,095 | 4,650 | 4,806 | 3,630 | 5,062 | 3,784 | 3,705 | 4,691 |
| Depreciation and amortization | 1,306 | 2,820 | 2,917 | 2,644 | 2,659 | 2,663 | 2,702 | 2,707 | 2,697 | 2,647 | 2,861 |
| Provision for credit losses | 35 | 49 | 39 | 52 | 78 | 99 | 128 | 58 | 73 | 90 | 123 |
| Deferred income taxes | -926 | -460 | -459 | -919 | -304 | -1,315 | -422 | -604 | -226 | -508 | -316 |
| Stock-based compensation | 439 | 375 | 348 | 344 | 290 | 297 | 344 | 359 | 355 | 393 | 429 |
| Loss on debt extinguishment | - | -163 | - | -38 | -457 | -406 | -308 | - | -53 | - | - |
| Asset Impairment Charges | - | - | - | - | - | - | - | 515 | - | 371 | - |
| Other, net | 134 | 111 | 93 | -117 | -257 | -217 | -251 | -138 | -270 | -573 | -310 |
| Accounts receivable, net | 413 | 435 | 75 | 275 | 581 | -1,291 | 761 | 477 | 576 | 391 | 433 |
| Inventories | 282 | 186 | 227 | 192 | 274 | 577 | -78 | 560 | 939 | 139 | 292 |
| Accounts payable and accrued liabilities | 1,616 | -65 | 356 | 65 | 399 | -44 | 531 | 213 | 696 | 391 | 209 |
| Other operating assets and liabilities | -643 | 403 | -85 | -229 | 624 | 609 | 549 | 65 | 148 | 345 | 538 |
| Net cash provided by operating activities | - | 5,218 | 6,880 | 4,684 | 7,007 | 7,234 | 6,240 | 7,346 | 6,039 | 6,787 | 7,044 |
| Acquisitions, net of cash acquired | 14,884 | 1,213 | 1,324 | 137 | 1,827 | 488 | 994 | 91 | 1,867 | 211 | 98 |
| Additions to property, plant, and equipment | 571 | 1,046 | 1,254 | 1,068 | 1,134 | 1,213 | 1,355 | 1,368 | 1,459 | 1,587 | 1,859 |
| Purchases of investments | 7,582 | 5,406 | 4,371 | 3,200 | 2,532 | 11,039 | 11,808 | 9,882 | 7,514 | 7,748 | 8,226 |
| Sales and maturities of investments | 5,890 | 9,924 | 5,356 | 4,227 | 4,683 | 9,574 | 11,345 | 9,692 | 7,343 | 7,441 | 8,495 |
| Other investing activities, net | -89 | 14 | -22 | 22 | -36 | 37 | 54 | 10 | -4 | 261 | 249 |
| Net cash used in investing activities | - | 2,245 | -1,571 | 5,858 | -774 | -3,203 | -2,866 | -1,659 | -3,493 | -2,366 | -1,937 |
| Change in current debt obligations, net | - | - | - | -249 | -713 | -17 | -311 | - | - | 1,073 | -1,070 |
| Proceeds from Short-Term Debt | - | - | - | - | - | - | 2,789 | - | 2,284 | - | - |
| Repayments from short-term borrowings (maturities greater than 90 days) | - | - | - | - | - | - | 2,853 | - | 2,279 | - | - |
| Issuance of long-term debt | 19,942 | - | 2,140 | 21 | 7,794 | 5,568 | 7,172 | - | 5,409 | - | 3,209 |
| Payments on long-term debt | 1,268 | 5,132 | 863 | 7,370 | 7,948 | 6,110 | 7,367 | 1 | 6,012 | - | - |
| Dividends to shareholders | 1,337 | 2,139 | 2,376 | 2,494 | 2,693 | 2,894 | 3,120 | 3,383 | 3,616 | 3,666 | 3,589 |
| Issuance of ordinary shares | 649 | 491 | 428 | 403 | 992 | 662 | 474 | 429 | 308 | 284 | 508 |
| Repurchase of ordinary shares | 1,920 | 2,830 | 3,544 | 2,171 | 2,877 | 1,326 | 652 | 2,544 | 645 | 2,138 | 3,235 |
| Other financing activities | -31 | 82 | 85 | -2 | 14 | -81 | -268 | 163 | -409 | -3 | -184 |
| Net cash used in financing activities | - | -9,543 | -3,283 | -11,954 | -5,431 | -4,198 | -4,136 | -5,336 | -4,960 | -4,450 | -4,361 |
| Effect of exchange rate changes on cash and cash equivalents | - | - | - | - | -78 | -86 | 215 | -231 | 243 | -230 | 188 |
| Net change in cash and cash equivalents | - | - | - | - | 724 | -253 | -547 | 121 | -2,171 | -259 | 934 |
| Income taxes | 632 | 1,379 | 1,029 | 2,542 | 1,558 | 878 | 1,250 | 996 | 1,548 | 1,622 | 1,819 |
| Interest | - | - | - | - | 973 | 643 | 582 | 540 | 606 | 826 | 762 |